Spironolactone Tablet, Film Coated
Product Images NDC 70518-4468

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70518-4468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)
Chemical structure of spironolactone, showing its steroid framework with characteristic lactone and thioester groups.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)
A Kaplan-Meier survival curve comparing the probability of an outcome over time (in months) between two groups: Spironolactone (n=822) and Placebo (n=841). The graph shows higher probability over time for Spironolactone versus Placebo, with a log-rank p-value of less than 0.001.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)
A forest plot displaying hazard ratios (HR) with 95% confidence intervals (CI) for various subgroups in a clinical study. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The x-axis ranges from 0.2 to 1.4, indicating comparative effect sizes between spironolactone and placebo.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Spironolactone 50 mg film-coated tablets packaging label from RemedyRepack Inc. This oral prescription drug package contains 100 tablets and includes storage instructions, lot number, expiration, and repackager contact information. The label notes the tablets are white and oval.*
FDA Label Image

Mm2 (Spironolactone 50mg 70518 4468 01)

Mm2 (Spironolactone 50mg 70518 4468 01)
Label for Spironolactone Tablet 50 mg film-coated tablet, quantity of 1 tablet. The label indicates the tablet is oval and white. It includes storage instructions to protect from light and keep out of reach of children, with recommended temperature ranges. The product is repackaged by RemedyRepack Inc., Indiana, PA, and the original manufacturer is Zydus Pharmaceuticals, Pennington, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.